U.S. welcomes transparency of China on H7N9
The State Department released the outcomes of the fifth round of the U.S. China Strategic and Economic Dialogue, which took place on Wednesday and Thursday in Washington. According to the report, the U.S. and China will attempt to improve cooperation when it comes to infectious disease response, including the response to malaria, multi-drug-resistant tuberculosis and influenza.
"The United States and China have decided to continue to strengthen extensive and transparent scientific cooperation on emerging and re-emerging infectious diseases, including influenza, multi-drug resistant tuberculosis, malaria, etc., with the purpose of protecting global health security," the department said.
The standards for cooperation were part of a new protocol the two countries signed. The protocol for cooperation in the science and technology of public health and medicine was signed by the U.S. Department of Health and Human Services and the Chinese National Health and Family Planning Commission.
Representatives from both sides, including U.S. Secretary of State John Kerry and Chinese State Councilor Yang Jiechi, held in-depth discussion on multiple issues related to the deepening strategic trust and the expansion of practical cooperation to develop a new model of relations between China and the U.S.